BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 18, 2008
View Archived Issues
Novel transglycosylase inhibitors with antibacterial activity discovered
Read More
Eisai updates Q3 progress
Read More
Intercell to develop tuberculosis vaccine formulated with adjuvant IC-31
Read More
FDA accepts Y's Therapeutics' IND application to conduct a phase I clinical trial of YSCMA
Read More
Fornix reports results from phase II/III AB0602 clinical study of Oralgen
Read More
DiaMedica reports positive results from preclinical study of DM-99
Read More
Pharmaxis to apply for MAA in Australia for Bronchitol for the treatment of bronchiectasis
Read More
Alvine initiates dosing in phase I clinical trial of ALV-003 for celiac disease
Read More
New therapeutic agents for urinary incontinence imparted in recent Takeda patents
Read More
Recent patents report new agents for neurological disorders
Read More
Novel analgesic agents described in recent patent literature
Read More
AstraZeneca announces creation of a new company Albireo
Read More
Biogen Idec and Cardiokine initiate a phase III study of lixivaptan
Read More
DelSite initiates production of clinical quantities of nasal powder bird flu vaccine
Read More
TorreyPines presents 2008 strategic plan for tezampanel, NGX-426, and NGX-267
Read More
Migenix provides pipeline update
Read More
Neuroprotective effects of lithium in preclinical and clinical studies of ALS
Read More
VRX-496 affects HIV replication in phase II trial
Read More
Activity of RDEA-806 less affected by human serum proteins than other NNRTIs
Read More
Improved body composition seen with tesamorelin in HIV-associated lipohypertrophy
Read More
FDA approves Abbott's Simcor, a combination therapy for cholesterol management
Read More
Vaccinex licenses human anti-interleukin-6 antibody to GlaxoSmithKline
Read More
JADO reports proof of concept with lipid raft modulator in atopic dermatitis patients
Read More
Canada approves Wellbutrin XL for prevention of seasonal major depressive illness
Read More
